Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
Authors:
Open Access
- 22 August 2022
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 20 (1) , 1-11
Abstract
Background: The relationship between non-alcoholic fatty liver degree as well as non-alcoholic fatty liver disease (NAFLD) and irritable bowel syndrome (IBS) remains poorly understood. We aimed to investigate the prospective association of non-alcoholic fatty liver degree as well as NAFLD with incident IBS in a large-scale population-based cohort. Methods: Participants free of IBS, coeliac disease, inflammatory bowel disease, alcoholic liver disease, and any cancer at baseline from the UK Biobank were included. Non-alcoholic fatty liver degree was measured by a well-validated fatty liver index (FLI), with FLI ≥ 60 as an indicator of NAFLD. Primary outcome was incident IBS. Cox proportional hazard model was used to investigate the associated risk of incident IBS. Results: Among 396,838 participants (mean FLI was 48.29 ± 30.07), 153,203(38.6%) were with NAFLD diagnosis at baseline. During a median of 12.4-year follow-up, 7129 cases of incident IBS were identified. Compared with non-NAFLD, NAFLD patients showed a 13% higher risk of developing IBS (HR = 1.13, 95%CI: 1.05–1.17) after multivariable adjustment. Compared with the lowest, the highest FLI quartile was associated with a significantly increased risk of IBS (HRQ4 VS Q1 = 1.21, 1.13–1.30, Ptrend < 0.001). Specifically, the positive association between non-alcoholic fatty liver degree and IBS was also observed by per SD change of FLI (adjusted HR = 1.08, 1.05–1.10). Further sensitivity analysis and subgroup analysis indicated similar results, with the positive association particularly observed in females, but not in males. Conclusions: High degree of non-alcoholic fatty liver as well as non-alcoholic fatty liver disease is associated with increased risk of incident IBS. Further studies are warranted to confirm the findings and elucidate the underlying biological mechanisms.Keywords
Funding Information
- National Natural Science Foundation of China (82070550)
This publication has 38 references indexed in Scilit:
- Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: Association with digestive symptoms and quality of lifeCytokine, 2017
- Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel SyndromeAmerican Journal of Gastroenterology, 2016
- Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokinesExpert Review of Gastroenterology & Hepatology, 2015
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old AgePLOS Medicine, 2015
- Non-alcoholic fatty liver disease, obesity and the metabolic syndromeBest Practice & Research Clinical Gastroenterology, 2014
- What does irritable bowel syndrome share with non-alcoholic fatty liver disease?World Journal of Gastroenterology, 2013
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver diseaseDigestive and Liver Disease, 2010
- The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general populationBMC Gastroenterology, 2006
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998
- DeprivationJournal of Social Policy, 1987